Kuros Biosurgery AG

KUROS TO PRESENT POSITIVE KUR-115 PRE CLINICAL DATA FOR INTERBODY SPINAL FUSION TREATMENT AT THE 2015 NORTH AMERICAN SPINE SOCIETY

Zurich, Switzerland, 15th October 2015 – Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products, today announces…